Nagsen Gautam

2.4k citations
62 papers · 1.5k indexed · h-index 23
Topics
HIV Research and Treatment (22 papers)HIV/AIDS drug development and treatment (21 papers)HIV/AIDS Research and Interventions (16 papers)

In The Last Decade

Nagsen Gautam

61 papers receiving 1.5k citations

Peers

Nagsen Gautam
Comparison fields: 5 of 111
  • Infectious Diseases 453
  • Virology 417
  • Molecular Biology 401
  • Oncology 239
  • Epidemiology 226
Replace Alain Pruvost with:
Alain Pruvost France
Yazen Alnouti United States
Rosa I. Sánchez United States
K C Cundy United States
Ana Blas‐García Spain
B. Diquet France
Byung Hwa Jung South Korea
Zhe Li China
Marc De Meulder Belgium
J. B. Fourtillan France
Nagsen Gautam relative to Alain Pruvost France Alain Pruvost's profile →
Citations per field
00.5×1.6×
Alain Pruvost · 1×
Citations per year

Countries citing papers authored by Nagsen Gautam

Since Specialization
Citations

This map shows the geographic impact of Nagsen Gautam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagsen Gautam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagsen Gautam more than expected).

Fields of papers citing papers by Nagsen Gautam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagsen Gautam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagsen Gautam. The network helps show where Nagsen Gautam may publish in the future.

Co-authorship network of co-authors of Nagsen Gautam

This figure shows the co-authorship network connecting the top 25 collaborators of Nagsen Gautam. A scholar is included among the top collaborators of Nagsen Gautam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagsen Gautam. Nagsen Gautam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 32
3 14
4 36
5 15
6 6
7 22
8 5
9 6
10 14
11 65
12 187
13 83
14 26
15 38
16 47
17 24
18 43
19 9
20 6

About Nagsen Gautam

Nagsen Gautam is a scholar working on Virology, Infectious Diseases and Pharmacology, having authored 62 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (21 papers) and HIV/AIDS Research and Interventions (16 papers). The work is most often cited by research in Virology (417 citations), Infectious Diseases (453 citations) and Biological Psychiatry (55 citations). Nagsen Gautam has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Yazen Alnouti, Rhishikesh Thakare, Jawaher Abdullah Alamoudi, Howard E. Gendelman, Benson Edagwa, Yashpal S. Chhonker, JoEllyn McMillan, A. David Rodrigues, Aditya N. Bade and Sai Praneeth Bathena. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026